Your browser doesn't support javascript.
loading
Risk Factors for Community-Associated Clostridium difficile Infection in Adults: A Case-Control Study.
Guh, Alice Y; Adkins, Susan Hocevar; Li, Qunna; Bulens, Sandra N; Farley, Monica M; Smith, Zirka; Holzbauer, Stacy M; Whitten, Tory; Phipps, Erin C; Hancock, Emily B; Dumyati, Ghinwa; Concannon, Cathleen; Kainer, Marion A; Rue, Brenda; Lyons, Carol; Olson, Danyel M; Wilson, Lucy; Perlmutter, Rebecca; Winston, Lisa G; Parker, Erin; Bamberg, Wendy; Beldavs, Zintars G; Ocampo, Valerie; Karlsson, Maria; Gerding, Dale N; McDonald, L Clifford.
Afiliação
  • Guh AY; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Adkins SH; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Li Q; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Bulens SN; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Farley MM; Emory University Department of Medicine, Atlanta, Georgia.
  • Smith Z; Georgia Emerging Infections Program, Decatur, Georgia.
  • Holzbauer SM; Atlanta Veterans Affairs Medical Center, Atlanta, Georgia.
  • Whitten T; Georgia Emerging Infections Program, Decatur, Georgia.
  • Phipps EC; Atlanta Veterans Affairs Medical Center, Atlanta, Georgia.
  • Hancock EB; Atlanta Research and Education Foundation, Decatur, Georgia.
  • Dumyati G; Minnesota Department of Health, St Paul, Minnesota.
  • Concannon C; Career Epidemiology Field Officer Program, Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Kainer MA; Minnesota Department of Health, St Paul, Minnesota.
  • Rue B; University of New Mexico, New Mexico Emerging Infections Program, Albuquerque, New Mexico.
  • Lyons C; University of New Mexico, New Mexico Emerging Infections Program, Albuquerque, New Mexico.
  • Olson DM; New York Emerging Infections Program and University of Rochester Medical Center, Rochester, New York.
  • Wilson L; New York Emerging Infections Program and University of Rochester Medical Center, Rochester, New York.
  • Perlmutter R; Tennessee Department of Health, Nashville, Tennessee.
  • Winston LG; Tennessee Department of Health, Nashville, Tennessee.
  • Parker E; Yale School of Public Health, Connecticut Emerging Infections Program, New Haven, Connecticut.
  • Bamberg W; Yale School of Public Health, Connecticut Emerging Infections Program, New Haven, Connecticut.
  • Beldavs ZG; Maryland Department of Health and Mental Hygiene, Baltimore, Maryland.
  • Ocampo V; Maryland Department of Health and Mental Hygiene, Baltimore, Maryland.
  • Karlsson M; University of California, San Francisco, School of Medicine, San Francisco, California.
  • Gerding DN; California Emerging Infections Program, Oakland, California.
  • McDonald LC; Colorado Department of Public Health and Environment, Denver, Colorado.
Open Forum Infect Dis ; 4(4): ofx171, 2017.
Article em En | MEDLINE | ID: mdl-29732377
ABSTRACT

BACKGROUND:

An increasing proportion of Clostridium difficile infections (CDI) in the United States are community-associated (CA). We conducted a case-control study to identify CA-CDI risk factors.

METHODS:

We enrolled participants from 10 US sites during October 2014-March 2015. Case patients were defined as persons age ≥18 years with a positive C. difficile specimen collected as an outpatient or within 3 days of hospitalization who had no admission to a health care facility in the prior 12 weeks and no prior CDI diagnosis. Each case patient was matched to one control (persons without CDI). Participants were interviewed about relevant exposures; multivariate conditional logistic regression was performed.

RESULTS:

Of 226 pairs, 70.4% were female and 52.2% were ≥60 years old. More case patients than controls had prior outpatient health care (82.1% vs 57.9%; P < .0001) and antibiotic (62.2% vs 10.3%; P < .0001) exposures. In multivariate analysis, antibiotic exposure-that is, cephalosporin (adjusted matched odds ratio [AmOR], 19.02; 95% CI, 1.13-321.39), clindamycin (AmOR, 35.31; 95% CI, 4.01-311.14), fluoroquinolone (AmOR, 30.71; 95% CI, 2.77-340.05) and beta-lactam and/or beta-lactamase inhibitor combination (AmOR, 9.87; 95% CI, 2.76-340.05),-emergency department visit (AmOR, 17.37; 95% CI, 1.99-151.22), white race (AmOR 7.67; 95% CI, 2.34-25.20), cardiac disease (AmOR, 4.87; 95% CI, 1.20-19.80), chronic kidney disease (AmOR, 12.12; 95% CI, 1.24-118.89), and inflammatory bowel disease (AmOR, 5.13; 95% CI, 1.27-20.79) were associated with CA-CDI.

CONCLUSIONS:

Antibiotics remain an important risk factor for CA-CDI, underscoring the importance of appropriate outpatient prescribing. Emergency departments might be an environmental source of CDI; further investigation of their contribution to CDI transmission is needed.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Geórgia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Geórgia